This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

The Genetics of Chiari Type I Malformation

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Duke University Identifier:
First received: February 1, 2010
Last updated: June 12, 2017
Last verified: April 2017
Duke University Medical Center is investigating the hereditary basis of Chiari type I malformations with or without syringomyelia (CM1/S). Our research is aimed at learning if CM1/S is indeed caused by factors inherited through the family and, if so, which genes are involved.

Chiari Type I Malformation

Study Type: Observational
Study Design: Observational Model: Family-Based
Time Perspective: Cross-Sectional
Official Title: The Genetics of Chiari Type I Malformation (CMI) With or Without Syringomyelia

Resource links provided by NLM:

Further study details as provided by Duke University:

Primary Outcome Measures:
  • Genetic factors contributing to Chiari Type I malformation [ Time Frame: end of study ]
    This study aims to identify genetic factors that contribute to or cause Chiari Type I malformation.

Biospecimen Retention:   Samples With DNA
Whole blood, serum, DNA

Estimated Enrollment: 2000
Study Start Date: June 2009
Estimated Study Completion Date: August 2020
Estimated Primary Completion Date: August 2020 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The study is not currently enrolling new participants.
The study is not currently enrolling new participants.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01060800

United States, North Carolina
Duke University Medical Center
Durham, North Carolina, United States, 27710
Sponsors and Collaborators
Duke University
Principal Investigator: Allison Ashley-Koch, PhD Duke University
  More Information

Additional Information:
Responsible Party: Duke University Identifier: NCT01060800     History of Changes
Other Study ID Numbers: Pro00011231
Study First Received: February 1, 2010
Last Updated: June 12, 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Duke University:
Chiari Type I
Chiari Type I Malformation
Familial Chiari

Additional relevant MeSH terms:
Congenital Abnormalities
Arnold-Chiari Malformation
Neural Tube Defects
Nervous System Malformations
Nervous System Diseases processed this record on September 21, 2017